Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease
Zhou Junfei, Gao Meihua, Shuai Zhang, Lu Xiangting, Lei Zhidan, Cheng Tian-ming, Liu Yajing, Tianshu Chu, Shi Lipu
Topics & Concepts
MedicineTofacitinibDLCOInternal medicineInterstitial lung diseaseGastroenterologyPulmonary function testingRheumatologyDiffusing capacityVital capacityPulmonary fibrosisLungJanus kinase inhibitorRheumatoid arthritisLung functionSystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInflammatory Myopathies and Dermatomyositis